Yuliya Aleksandrovna Pogorelova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuliya Aleksandrovna Pogorelova has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Elena Mikhaylovna Frantsiyants
National Medical Research Center of Oncology, Ministry of Health of Russia
33 shared publications - Irina Viktorovna Kaplieva
Rostov Research Institute of Oncology
27 shared publications - Valeriya Akhtyamovna Bandovkina
National Medical Research Center of Oncology, Ministry of Health of Russia
26 shared publications - Ekaterina Igorevna Surikova
National Medical Research Centre for Oncology Rostov-on-Don, Russian Federation
23 shared publications - Natal'YA Dmitrievna Cheryarina
National Medical Research Center of Oncology, Ministry of Health of Russia
22 shared publications - Irina Valer'EVna Neskubina
National Medical Research Center of Oncology, Ministry of Health of Russia
21 shared publications
Latest Publications
- 30 June 2025
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 13 (2)
Content of Monoamines in Blood and Tumor Tissue in Patients with Bladder Cancer Depending on the Presence of Diabetes Mellitus
INTRODUCTION: According to the literature, the risk of developing bladder cancer (BC) which is included in the top ten most common cancers in the world and characterized by a tendency to recurrence and metastasizing may be associated with the existence of diabetes mellitus (DM) in patients. Monoamines are known to be involved in the proliferation and dissemination processes, and can affect the immune and endothelial cells in the tumor micro-environment contributing to the progression of tumor growth. Impaired serotonin metabolism is considered an unfavorable factor of the development of diabetic pathology, which underlies the interest in investigation of the influence of diabetes mellitus on the content and metabolism of monoamines in patients with BC. AIM: To assess the content of biogenic monoamines in blood and tumor tissue in BC patients with and without DM. MATERIALS AND METHODS: The work includes data from 22 patients with non-muscle invasive BC, divided into two groups of 11 patients each depending on the presence of type 2 diabetes (DM2), and also two comparison groups: 11 persons without oncological diseases and DM (donors) and 8 persons without oncological diseases with DM2. The content of dopamine (DA), norepinephrine (NA), serotonin (SR) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) obtained in transurethral resection in patients with bladder cancer, was determined in blood plasma and in 10% tumor tissue homogenates using enzyme immunoassay. RESULTS: Patients with BC with and without DM, were characterized by more than three times decrease in the blood level of NA relative to the donor group, without statistically significant changes in the contents of DA and SR, as well as by three to four times decrease in the ratio of NA to DA and SR in most patients. Tumor tissue in patients with DM was characterized by a lower content of NA and 5-HIAA and also by two and a half times decrease in 5-HIAA to SR ratio. At the same time, in patients with DM2 (without cancer), an almost two times increase in 5-HIAA/SR index in the blood and urine was observed, indicating a possible role of monoamine oxidase (MAO) activation, contributing to the development of MAO-dependent oxidative stress in diabetes. CONCLUSION: The obtained data suggest the participation of monoamines, changes in their proportion and metabolism in realization of the influence of DM on the course of malignant disease.
- 30 June 2025
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 13 (2)
Content of Monoamines in Blood and Tumor Tissue in Patients with Bladder Cancer Depending on the Presence of Diabetes Mellitus
INTRODUCTION: According to the literature, the risk of developing bladder cancer (BC) which is included in the top ten most common cancers in the world and characterized by a tendency to recurrence and metastasizing may be associated with the existence of diabetes mellitus (DM) in patients. Monoamines are known to be involved in the proliferation and dissemination processes, and can affect the immune and endothelial cells in the tumor micro-environment contributing to the progression of tumor growth. Impaired serotonin metabolism is considered an unfavorable factor of the development of diabetic pathology, which underlies the interest in investigation of the influence of diabetes mellitus on the content and metabolism of monoamines in patients with BC. AIM: To assess the content of biogenic monoamines in blood and tumor tissue in BC patients with and without DM. MATERIALS AND METHODS: The work includes data from 22 patients with non-muscle invasive BC, divided into two groups of 11 patients each depending on the presence of type 2 diabetes (DM2), and also two comparison groups: 11 persons without oncological diseases and DM (donors) and 8 persons without oncological diseases with DM2. The content of dopamine (DA), norepinephrine (NA), serotonin (SR) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) obtained in transurethral resection in patients with bladder cancer, was determined in blood plasma and in 10% tumor tissue homogenates using enzyme immunoassay. RESULTS: Patients with BC with and without DM, were characterized by more than three times decrease in the blood level of NA relative to the donor group, without statistically significant changes in the contents of DA and SR, as well as by three to four times decrease in the ratio of NA to DA and SR in most patients. Tumor tissue in patients with DM was characterized by a lower content of NA and 5-HIAA and also by two and a half times decrease in 5-HIAA to SR ratio. At the same time, in patients with DM2 (without cancer), an almost two times increase in 5-HIAA/SR index in the blood and urine was observed, indicating a possible role of monoamine oxidase (MAO) activation, contributing to the development of MAO-dependent oxidative stress in diabetes. CONCLUSION: The obtained data suggest the participation of monoamines, changes in their proportion and metabolism in realization of the influence of DM on the course of malignant disease.
- Open Access
- 12 January 2025
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 23 (6) , 70-80
Establishment of an orthotopic model of endometrial cancer
The purpose of this study was to establish a model of uterine carcinoma in female laboratory rats by transplanting Guerin carcinoma directly into the uterine horn. Material and Methods. Fifteen nonlinear white laboratory rats weighing 250 ± 25 g served as the subjects of surgical intervention. all operative interventions were performed under xylazine-zoletil anesthesia. Female white laboratory rats were laparotomized under aseptic conditions using anesthesia. the incision length was 2 cm, and a tumor suspension containing 2.5-3.5×106 cells was injected into the lumen of the right uterine horn using an intravenous catheter with a 22G injection port (0.9 × 25 mm). tumor cells were counted using the ADAMIILS cell analyzer (Nano Entek, Korea). the tumor progression was monitored for 21 days. after euthanizing the animals under ether anesthesia, median longitudinal histological sections, 5–7 μm thick, were made from the tumor node and stained with hematoxylin-eosin and Van-Gizon using standard techniques. Results. Following the transplantation of Guerin’s carcinoma cell suspension, a tumor node of approximately 25 mm in diameter was identified macroscopically in the region of the inferior aspect of the right uterine horn. additionally, the presence of haemorrhagic effusion was documented in the abdominal cavity and tumor screenings. at light microscopy, areas of neutrophilic infiltration, significant narrowing of the lumen of the uterine horn with signs of involution, and prismatic epithelium of papillary structures were observed. the tumor cell features characteristic of Guerin’s carcinoma are preserved in the tumor node induced in the uterus, with a cytoplasmic-nuclear ratio that remains close to 1:1. the shapes of the nuclei vary, but the irregular ovoid shape remains dominant, and pathological mitotic figures are observed. the tumor stroma includes cytoplasmic branched connections connecting the tumor conglomeration. Conclusion. therefore, according to the morphological description, the presented experimental model demonstrates the possibility of intrauterine growth of Guerin’s carcinoma in animals and is most similar to the localization of the tumor focus in patients with gynecological cancer.
- 12 January 2025
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 23 (6) , 70-80
Open AccessEstablishment of an orthotopic model of endometrial cancer
The purpose of this study was to establish a model of uterine carcinoma in female laboratory rats by transplanting Guerin carcinoma directly into the uterine horn. Material and Methods. Fifteen nonlinear white laboratory rats weighing 250 ± 25 g served as the subjects of surgical intervention. all operative interventions were performed under xylazine-zoletil anesthesia. Female white laboratory rats were laparotomized under aseptic conditions using anesthesia. the incision length was 2 cm, and a tumor suspension containing 2.5-3.5×106 cells was injected into the lumen of the right uterine horn using an intravenous catheter with a 22G injection port (0.9 × 25 mm). tumor cells were counted using the ADAMIILS cell analyzer (Nano Entek, Korea). the tumor progression was monitored for 21 days. after euthanizing the animals under ether anesthesia, median longitudinal histological sections, 5–7 μm thick, were made from the tumor node and stained with hematoxylin-eosin and Van-Gizon using standard techniques. Results. Following the transplantation of Guerin’s carcinoma cell suspension, a tumor node of approximately 25 mm in diameter was identified macroscopically in the region of the inferior aspect of the right uterine horn. additionally, the presence of haemorrhagic effusion was documented in the abdominal cavity and tumor screenings. at light microscopy, areas of neutrophilic infiltration, significant narrowing of the lumen of the uterine horn with signs of involution, and prismatic epithelium of papillary structures were observed. the tumor cell features characteristic of Guerin’s carcinoma are preserved in the tumor node induced in the uterus, with a cytoplasmic-nuclear ratio that remains close to 1:1. the shapes of the nuclei vary, but the irregular ovoid shape remains dominant, and pathological mitotic figures are observed. the tumor stroma includes cytoplasmic branched connections connecting the tumor conglomeration. Conclusion. therefore, according to the morphological description, the presented experimental model demonstrates the possibility of intrauterine growth of Guerin’s carcinoma in animals and is most similar to the localization of the tumor focus in patients with gynecological cancer.
- 27 December 2024
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
- No. 4
CHARACTERISTICS OF MITOCHONDRIAL CYTOCHROME C DISTRIBUTION IN PATIENTS WITH COLORECTAL CANCER
Understanding the mechanisms of colorectal cancer development and progression is important for disease management. Mitochondria being the energy source of eukaryotic cells play a significant role in intestinal homeostasis. Objective: The aim of the study is to examine cytochrome C level in mitochondria isolated from cells of different parts of the colon in men and women. Materials and Methods. The authors analyzed the materials obtained from 132 patients with colon cancer T2-3N0M0 (52 women and 80 men). Mitochondria from human intestinal and tumor tissue cells were isolated by differential centrifugation. Then, cytochrome C concentration (ng/mg protein) was determined by ELISA. Results. When studying the cytochrome C level in tumor tissue from various parts of the colon in men, we found that cytochrome C level in tumor mitochondria of the rectum, sigmoid colon and ascending colon was higher than that in the mitochondrial cells of the corresponding tissues by 1.8, 1.5 and 2.0 times, respectively. In women, cytochrome C level in the mitochondrial tumors of the same parts of the colon was higher than that in the mitochondria of the corresponding tissues by 2.9, 1.4 and 2.0 times, respectively. Conclusion. A common pathological characteristics of tumor mitochondria in all parts of the colon was a high cytochrome C level. It may be associated with the intensification of cellular respiration processes in the tumor contributing to its growth.
- 27 December 2024
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
- No. 4
CHARACTERISTICS OF MITOCHONDRIAL CYTOCHROME C DISTRIBUTION IN PATIENTS WITH COLORECTAL CANCER
Understanding the mechanisms of colorectal cancer development and progression is important for disease management. Mitochondria being the energy source of eukaryotic cells play a significant role in intestinal homeostasis. Objective: The aim of the study is to examine cytochrome C level in mitochondria isolated from cells of different parts of the colon in men and women. Materials and Methods. The authors analyzed the materials obtained from 132 patients with colon cancer T2-3N0M0 (52 women and 80 men). Mitochondria from human intestinal and tumor tissue cells were isolated by differential centrifugation. Then, cytochrome C concentration (ng/mg protein) was determined by ELISA. Results. When studying the cytochrome C level in tumor tissue from various parts of the colon in men, we found that cytochrome C level in tumor mitochondria of the rectum, sigmoid colon and ascending colon was higher than that in the mitochondrial cells of the corresponding tissues by 1.8, 1.5 and 2.0 times, respectively. In women, cytochrome C level in the mitochondrial tumors of the same parts of the colon was higher than that in the mitochondria of the corresponding tissues by 2.9, 1.4 and 2.0 times, respectively. Conclusion. A common pathological characteristics of tumor mitochondria in all parts of the colon was a high cytochrome C level. It may be associated with the intensification of cellular respiration processes in the tumor contributing to its growth.
- Open Access
- 4 December 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (4) , 58-72
Uterine sarcoma: the possibility of modeling a rare tumor and providing its morphological description
Purpose of the study. To create a model of uterine sarcoma in female white mongrel rats and provide description of its morphological features. Materials and methods. In the in vivo experiment, white mongrel female laboratory rats (n = 20) weighing 250 ± 25 g were used, and the M1 strain of rat sarcoma was used as an experimental tumor model. The studied groups of animals: Group 1 (n = 10) – administration of 0.5 ml of tumor suspension containing 2.5–3.5 × 106 cells using an intravenous catheter with an injection port 22G, 0.9 × 25 mm; group 2 (n = 10) – donors of tumor material with subcutaneous M1 grafting according to the standard method. Xylazine‑ zolethyl anesthesia was used during surgical interventions. The duration of the experiment was 21 days. After killing the animals, median longitudinal histological sections were made from the tumor node, 5–7 microns thick, stained with hematoxylin‑ eosin. Results. Unlike subcutaneous grafting of sarcoma M1, the tumor growing in the uterine horn was characterized by the presence in the abdominal cavity of many nodules and tumor dropouts on the mesentery, i. e. lymph nodes. According to the cellular composition, tumors formed from a suspension of M1 sarcoma cells injected into the right horn of the uterus were characterized by a polymorphocellular type of structure against the background of pronounced neoangiogenesis. Necrosis and hemorrhages were noted in certain sections of the preparations with a polyp‑like tumor form, which corresponds to destructive signs of rapid growth and development of uterine sarcoma. Conclusion. The possibility of modeling a relatively rare tumor by introducing a suspension of M1 sarcoma cells into the right uterine horn of female rats has been established. The nature of multinodular tumor growth with pronounced polymorphism of the cellular composition, areas of necrotization and hemorrhage demonstrates the adequacy of the uterine sarcoma model for the implementation of research tasks in clinical oncology.
- 4 December 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (4) , 58-72
Open AccessUterine sarcoma: the possibility of modeling a rare tumor and providing its morphological description
Purpose of the study. To create a model of uterine sarcoma in female white mongrel rats and provide description of its morphological features. Materials and methods. In the in vivo experiment, white mongrel female laboratory rats (n = 20) weighing 250 ± 25 g were used, and the M1 strain of rat sarcoma was used as an experimental tumor model. The studied groups of animals: Group 1 (n = 10) – administration of 0.5 ml of tumor suspension containing 2.5–3.5 × 106 cells using an intravenous catheter with an injection port 22G, 0.9 × 25 mm; group 2 (n = 10) – donors of tumor material with subcutaneous M1 grafting according to the standard method. Xylazine‑ zolethyl anesthesia was used during surgical interventions. The duration of the experiment was 21 days. After killing the animals, median longitudinal histological sections were made from the tumor node, 5–7 microns thick, stained with hematoxylin‑ eosin. Results. Unlike subcutaneous grafting of sarcoma M1, the tumor growing in the uterine horn was characterized by the presence in the abdominal cavity of many nodules and tumor dropouts on the mesentery, i. e. lymph nodes. According to the cellular composition, tumors formed from a suspension of M1 sarcoma cells injected into the right horn of the uterus were characterized by a polymorphocellular type of structure against the background of pronounced neoangiogenesis. Necrosis and hemorrhages were noted in certain sections of the preparations with a polyp‑like tumor form, which corresponds to destructive signs of rapid growth and development of uterine sarcoma. Conclusion. The possibility of modeling a relatively rare tumor by introducing a suspension of M1 sarcoma cells into the right uterine horn of female rats has been established. The nature of multinodular tumor growth with pronounced polymorphism of the cellular composition, areas of necrotization and hemorrhage demonstrates the adequacy of the uterine sarcoma model for the implementation of research tasks in clinical oncology.
- Open Access
- 7 November 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (4) , 23-35
Tumor and peritumoral tissue hormonal background features in patients with rare types of endometrial cancer
Serous endometrial intraepithelial carcinoma (SEIC) and clear cell carcinoma of the endometrium (CCEC) belong to pathogenetic type II without evidence of hyperestrogenism, are often detected late in the course of the disease, and are characterized by an aggressive course. Currently, there is increasing interest in the role of local content and metabolism of steroid hormones in organs and tissues in various pathologies, including the development of malignant tumors. Purpose of the study. To determine the local level of sex hormones in patients with SEIC and CCEC. Patients and methods. The study included 21 patients with SEIC and 20 patients with CCEC. The control group consisted of 20 patients who had undergone surgical treatment for uterine myoma. All patients were treated at the National Medical Research Center for Oncology, Rostov‑on‑ Don, the Russian Federation Ministry of Health. The local levels of estrogens and androgens were determined in the tumor tissue, the perifocal zone, endometrial tissue unaffected by the tumor process, and the fallopian tube tissue in patients with SEIC and CCEC. In the control group, the local level of sex hormones was determined in intact 10 % homogenic endometrial tissue. Results. The data were analyzed, and the results demonstrated that the tumors and peritumoral tissues exhibited a depletion of estradiol (E2), a saturation of testosterone, and an extreme saturation of estriol (E3). The consequence of this imbalance was the predominance of fetal placental estrogen (E3), which was detected not only in the tumor tissue but also in distant parts of the endometrium and uterine tubes. In these regions, the concentration of E3 exceeded that of intact endometrium by a factor of more than five. A comparison of estrogen receptor (ER) levels revealed elevated levels in samples of the tumor, its perifocal zone, distant endometrium, and fallopian tubes. This finding indicated a predominance of ERα over ERβ. Conclusion. The local hormonal background of rare forms of non‑endometrioid endometrial carcinomas exhibits distinctive characteristics, including the replacement of the influence of classical estrogen (E2) by fetal, placental E3. Additionally, there is a notable prevalence of the REα type over REβ, along with hyperandrogenization of tissues, which culminates in the formation of a unique low‑differentiated tumor with pronounced biological aggressiveness.
- 7 November 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (4) , 23-35
Open AccessTumor and peritumoral tissue hormonal background features in patients with rare types of endometrial cancer
Serous endometrial intraepithelial carcinoma (SEIC) and clear cell carcinoma of the endometrium (CCEC) belong to pathogenetic type II without evidence of hyperestrogenism, are often detected late in the course of the disease, and are characterized by an aggressive course. Currently, there is increasing interest in the role of local content and metabolism of steroid hormones in organs and tissues in various pathologies, including the development of malignant tumors. Purpose of the study. To determine the local level of sex hormones in patients with SEIC and CCEC. Patients and methods. The study included 21 patients with SEIC and 20 patients with CCEC. The control group consisted of 20 patients who had undergone surgical treatment for uterine myoma. All patients were treated at the National Medical Research Center for Oncology, Rostov‑on‑ Don, the Russian Federation Ministry of Health. The local levels of estrogens and androgens were determined in the tumor tissue, the perifocal zone, endometrial tissue unaffected by the tumor process, and the fallopian tube tissue in patients with SEIC and CCEC. In the control group, the local level of sex hormones was determined in intact 10 % homogenic endometrial tissue. Results. The data were analyzed, and the results demonstrated that the tumors and peritumoral tissues exhibited a depletion of estradiol (E2), a saturation of testosterone, and an extreme saturation of estriol (E3). The consequence of this imbalance was the predominance of fetal placental estrogen (E3), which was detected not only in the tumor tissue but also in distant parts of the endometrium and uterine tubes. In these regions, the concentration of E3 exceeded that of intact endometrium by a factor of more than five. A comparison of estrogen receptor (ER) levels revealed elevated levels in samples of the tumor, its perifocal zone, distant endometrium, and fallopian tubes. This finding indicated a predominance of ERα over ERβ. Conclusion. The local hormonal background of rare forms of non‑endometrioid endometrial carcinomas exhibits distinctive characteristics, including the replacement of the influence of classical estrogen (E2) by fetal, placental E3. Additionally, there is a notable prevalence of the REα type over REβ, along with hyperandrogenization of tissues, which culminates in the formation of a unique low‑differentiated tumor with pronounced biological aggressiveness.
- Open Access
- 18 October 2024
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 23 (5) , 89-103
Dynamics of Free Radical Oxidative Processes During the Latent Period of Experimental Metastasizing to the Liver
Purpose — to investigate the dynamics of the content of antioxidant enzymes superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPO1), glutathione reductase (GR) and lipid peroxidation products diene conjugates (DC), malondialdehyde (MDA) in the spleen and liver during the latent period of growth and metastasis of experimental tumor.Materials and methods. Using 28 white male rats, a model of hematogenous liver metastasis was created by transplanting sarcoma 45 cells (S45) into the spleen, previously lead out under the skin 3 weeks before. Previously, was determined that a tumor visualized in the spleen at 5 weeks, and liver metastases at 7 weeks after transplantation S45. Levels of SOD1, GPO1, GR and MDA were determined using ELISA and DC by biochemical method in spleen and liver homogenates during the latent period of tumor growth and metastasis (1–2 weeks post-transplantation).Results. Significant changes (1.5–5.2 times, р < 0.050–0.001) in studied factors levels were observed compared to intact rats and rats with the spleen lead out. Activation of lipid peroxidation and antioxidant system was noted in the spleen (tumor-carrying organ) during tumor growth and metastasis. At the same time, in the liver (the target organ of metastasis) observed also increased lipid peroxidation but simultaneously a pronounced decreased GR levels (5 times, p < 0.001) without affecting SOD1 levels.Conclusion. Liver tissue exhibited the inferiority of antioxidant protection and the formation of pro-oxidant condition during the latent period of tumor growth, which may prepare the soil for metastasis.
- 18 October 2024
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 23 (5) , 89-103
Open AccessDynamics of Free Radical Oxidative Processes During the Latent Period of Experimental Metastasizing to the Liver
Purpose — to investigate the dynamics of the content of antioxidant enzymes superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPO1), glutathione reductase (GR) and lipid peroxidation products diene conjugates (DC), malondialdehyde (MDA) in the spleen and liver during the latent period of growth and metastasis of experimental tumor.Materials and methods. Using 28 white male rats, a model of hematogenous liver metastasis was created by transplanting sarcoma 45 cells (S45) into the spleen, previously lead out under the skin 3 weeks before. Previously, was determined that a tumor visualized in the spleen at 5 weeks, and liver metastases at 7 weeks after transplantation S45. Levels of SOD1, GPO1, GR and MDA were determined using ELISA and DC by biochemical method in spleen and liver homogenates during the latent period of tumor growth and metastasis (1–2 weeks post-transplantation).Results. Significant changes (1.5–5.2 times, р < 0.050–0.001) in studied factors levels were observed compared to intact rats and rats with the spleen lead out. Activation of lipid peroxidation and antioxidant system was noted in the spleen (tumor-carrying organ) during tumor growth and metastasis. At the same time, in the liver (the target organ of metastasis) observed also increased lipid peroxidation but simultaneously a pronounced decreased GR levels (5 times, p < 0.001) without affecting SOD1 levels.Conclusion. Liver tissue exhibited the inferiority of antioxidant protection and the formation of pro-oxidant condition during the latent period of tumor growth, which may prepare the soil for metastasis.
- Open Access
- 15 September 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (3) , 54-64
Antitumor effect of a new human epidermal growth factor receptor inhibitor
Purpose of the study. Preclinical study in experiment of antitumor efficacy of a new substance synthesized on the basis of pyrimidin-4-one derivative. Materials and methods. The sodium salt of 4-{2-[2-[2-(4-hydroxy-3-methoxyphenyl)-vinyl]-6-ethyl-4-oxo-5-phenyl-4H-pyrimidin-1-yl}-benzsulfamide, a new inhibitor of the internal domain of the epidermal growth factor receptor (EGFR), was used in this study. All C57BL6 mice of both sexes were subcutaneously transplanted with B16/F10 melanoma. Twenty-four hours after tumor transplantation, mice in the main group (n = 18) were injected with a new EGFR inhibitor intramuscularly at a dose of 0.375 mg per mouse (15,0 mg/kg animal masses), while mice in the control group (n = 18) were injected with saline for injection. In both groups administration was carried out before natural death of animals according to the scheme: administration daily for 5 days, followed by 2 days of break. The dynamics of animal weight, dynamics of tumor node volume were evaluated, the tumor growth inhibition index (TGII) was calculated. Results. Tumor visualization time and animal weight did not statistically significantly differ between the groups during the whole study. In the main group there was a longer lifespan by 1.5 times on average (p ≤ 0.05), and smaller average tumor volume (by 19.2 times on 14 days in males, by 4.3 times in females, by 4.3 times on 28 days in males, by 2.5 times in females, p ≤ 0.05) than in the control group. At the same time, in the main group the tumor volume was smaller in males by 2.7 and 1.8 times (p ≤ 0.05), respectively on days 25 and 28 than in females. TGII in mice of both sexes was maximal on the 14th day with subsequent decrease by 40.3 % in females and only by 18.6 % in males, and during the whole experiment TGII in males was higher. Conclusion. The results showed inhibition of melanoma growth and increased lifespan of mice of both sexes (more pronounced in males) in the group with administration of a new EGFR inhibitor. This indicates the promising potential of this compound and the need to continue its preclinical study in other tumor models.
- 15 September 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (3) , 54-64
Open AccessAntitumor effect of a new human epidermal growth factor receptor inhibitor
Purpose of the study. Preclinical study in experiment of antitumor efficacy of a new substance synthesized on the basis of pyrimidin-4-one derivative. Materials and methods. The sodium salt of 4-{2-[2-[2-(4-hydroxy-3-methoxyphenyl)-vinyl]-6-ethyl-4-oxo-5-phenyl-4H-pyrimidin-1-yl}-benzsulfamide, a new inhibitor of the internal domain of the epidermal growth factor receptor (EGFR), was used in this study. All C57BL6 mice of both sexes were subcutaneously transplanted with B16/F10 melanoma. Twenty-four hours after tumor transplantation, mice in the main group (n = 18) were injected with a new EGFR inhibitor intramuscularly at a dose of 0.375 mg per mouse (15,0 mg/kg animal masses), while mice in the control group (n = 18) were injected with saline for injection. In both groups administration was carried out before natural death of animals according to the scheme: administration daily for 5 days, followed by 2 days of break. The dynamics of animal weight, dynamics of tumor node volume were evaluated, the tumor growth inhibition index (TGII) was calculated. Results. Tumor visualization time and animal weight did not statistically significantly differ between the groups during the whole study. In the main group there was a longer lifespan by 1.5 times on average (p ≤ 0.05), and smaller average tumor volume (by 19.2 times on 14 days in males, by 4.3 times in females, by 4.3 times on 28 days in males, by 2.5 times in females, p ≤ 0.05) than in the control group. At the same time, in the main group the tumor volume was smaller in males by 2.7 and 1.8 times (p ≤ 0.05), respectively on days 25 and 28 than in females. TGII in mice of both sexes was maximal on the 14th day with subsequent decrease by 40.3 % in females and only by 18.6 % in males, and during the whole experiment TGII in males was higher. Conclusion. The results showed inhibition of melanoma growth and increased lifespan of mice of both sexes (more pronounced in males) in the group with administration of a new EGFR inhibitor. This indicates the promising potential of this compound and the need to continue its preclinical study in other tumor models.
- Open Access
- 30 August 2024
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 44 (4) , 105-112
Age-related characteristics of the content and activity of certain components of the blood fibrinolytic system in cases of uterine cancer
Uterine cancer (UC) is the third most common cancer in women in Russia. Knowledge of age-specific features of the fibrinolytic system in patients with UC can be useful in terms of improving its pathogenetic therapy. Aim of the study was to investigate the peculiarities of the content and activity of some components of the fibrinolytic system in the blood of UC patients of different age groups. Material and methods. 30 healthy women (donors) and 56 patients with uterine cancer T1a-2N0M0, adenocarcinoma G1–G3 were divided into subgroups according to age: reproductive, perimenopause and menopause. ELISA of urokinase (u-PA), its receptor (u-PAR) and its inhibitor (PAI-1), tissue-type plasminogen activator (t-PA) content were performed in blood collected before treatment. Results. In reproductive UC patients, inhibitor u-PA (PAI-1) activity increased 14-fold (hereinafter the difference is statistically significant, p < 0.05) and content increased 2.9-fold, while receptor u-PA (u-PAR) level decreased 1.7-fold compared to reproductive donors. Perimenopausal UC patients showed a 3.3-fold increase in PAI-1 content and a 6.3-fold increase in PAI-1 activity compared to perimenopausal donors, t-PA concentration decreased 1.3-fold relative to donors and was 1.9-fold lower than in reproductive UC patients. In menopausal patients with UC, the activity and content of PAI-1 enhanced 5.5-fold and 4.5-fold, respectively, compared to donors. Additionally, they were 2.1-fold and 1.2-fold lower than in reproductive UC patients. The activity of u-PA increased 2.6-fold, reaching the values of reproductive UC patients. The activity of t-PA was 1.3-fold higher than in donors, but did not differ from the activity in other RTM patients, while the level of t-PA occupied an intermediate position between the corresponding indices in young UC patients (it was 1.4-fold lower) and perimenopausal UC patients (it was 1.4-fold higher). Conclusions. The development of UC is accompanied by an imbalance of components of the fibrinolytic system in the blood, depending on the age of women, with a minimum spectrum of changes in the indicators in reproductive patients and maximum - in menopause patients, which indicates the pathognomonicity of these factors in PTM and requires an individual approach to the management of such patients.
- 30 August 2024
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 44 (4) , 105-112
Open AccessAge-related characteristics of the content and activity of certain components of the blood fibrinolytic system in cases of uterine cancer
Uterine cancer (UC) is the third most common cancer in women in Russia. Knowledge of age-specific features of the fibrinolytic system in patients with UC can be useful in terms of improving its pathogenetic therapy. Aim of the study was to investigate the peculiarities of the content and activity of some components of the fibrinolytic system in the blood of UC patients of different age groups. Material and methods. 30 healthy women (donors) and 56 patients with uterine cancer T1a-2N0M0, adenocarcinoma G1–G3 were divided into subgroups according to age: reproductive, perimenopause and menopause. ELISA of urokinase (u-PA), its receptor (u-PAR) and its inhibitor (PAI-1), tissue-type plasminogen activator (t-PA) content were performed in blood collected before treatment. Results. In reproductive UC patients, inhibitor u-PA (PAI-1) activity increased 14-fold (hereinafter the difference is statistically significant, p < 0.05) and content increased 2.9-fold, while receptor u-PA (u-PAR) level decreased 1.7-fold compared to reproductive donors. Perimenopausal UC patients showed a 3.3-fold increase in PAI-1 content and a 6.3-fold increase in PAI-1 activity compared to perimenopausal donors, t-PA concentration decreased 1.3-fold relative to donors and was 1.9-fold lower than in reproductive UC patients. In menopausal patients with UC, the activity and content of PAI-1 enhanced 5.5-fold and 4.5-fold, respectively, compared to donors. Additionally, they were 2.1-fold and 1.2-fold lower than in reproductive UC patients. The activity of u-PA increased 2.6-fold, reaching the values of reproductive UC patients. The activity of t-PA was 1.3-fold higher than in donors, but did not differ from the activity in other RTM patients, while the level of t-PA occupied an intermediate position between the corresponding indices in young UC patients (it was 1.4-fold lower) and perimenopausal UC patients (it was 1.4-fold higher). Conclusions. The development of UC is accompanied by an imbalance of components of the fibrinolytic system in the blood, depending on the age of women, with a minimum spectrum of changes in the indicators in reproductive patients and maximum - in menopause patients, which indicates the pathognomonicity of these factors in PTM and requires an individual approach to the management of such patients.
- Open Access
- 21 August 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (3) , 24-37
Age-related features of some plasminogen activation system components content and activity in the blood of benign and malignant uterine body tumors
Purpose of the study. Is to determine the features in the content and activity of some components of the plasminogen activation system in the blood of patients of different ages with leiomyomas (LM) and uterine corpus endometrial cancer (UCEC). Patients and methods. The study was carried out in patients with LM (n = 35) and UCEC T1a-2N0M0 (n = 56) of reproductive, perimenopausal and postmenopausal ages. Using ELISA methods, the content and activity of urokinase (u-PA), tissue plasminogen activator (t-PA), their inhibitor PAI-1, as well as the content of the soluble form of the u-PA receptor (su-PAR) were determined in the blood of patients. The Student´s test was used for statistical processing. Results. Regardless of the nature of the uterus tumor, it has been noted a significant increase in the activity and blood level of PAI-1 (up to 8 times, p < 0.01), especially pronounced in patients with UCEC of reproductive age. It was combined with the absence of changes or with a decreasing in blood level of su-PAR by more than 40 % (p < 0.05). We observed a rise of u-PA blood level without changes in one´s activity in patients with LM of perimenopausal age. And in patients with LM and UCEC of postmenopausal age an increase in u-PA blood level as well as elevation of u-PA activity (up to 3.9 times, p < 0.01–0.05) were noted. There was an increase in the calculated t-PA index (activity per unit mass) by 1.4–2.8 times (p < 0.05) in the most patients. The indicators of LM patients were characterized by the minimum value of the ratio “t-PA activity/u-PA activity in the blood” among all studied subgroups of patients. Age-related features of the researched parameters were observed more often in the cases of LM than in the cases of UCEC. The most pronounced differences between LM and UCEC were observed in patients of reproductive and postmenopausal age, characterized by stable hormonal levels. Conclusion. The participation of the plasminogen activation system in the pathogenesis of tumor lesions of the uterine body has been shown. The system’s “response” to the development of tumors in the uterus has both general characteristics and features that depend on the nature of the tumors and on the age-specific hormonal regulation of the body, which are most pronounced in postmenopausal women. The results obtained can be used in research aimed at clarifying the targets of targeted therapy for LM and UCEC in accordance with the age of patients.
- 21 August 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (3) , 24-37
Open AccessAge-related features of some plasminogen activation system components content and activity in the blood of benign and malignant uterine body tumors
Purpose of the study. Is to determine the features in the content and activity of some components of the plasminogen activation system in the blood of patients of different ages with leiomyomas (LM) and uterine corpus endometrial cancer (UCEC). Patients and methods. The study was carried out in patients with LM (n = 35) and UCEC T1a-2N0M0 (n = 56) of reproductive, perimenopausal and postmenopausal ages. Using ELISA methods, the content and activity of urokinase (u-PA), tissue plasminogen activator (t-PA), their inhibitor PAI-1, as well as the content of the soluble form of the u-PA receptor (su-PAR) were determined in the blood of patients. The Student´s test was used for statistical processing. Results. Regardless of the nature of the uterus tumor, it has been noted a significant increase in the activity and blood level of PAI-1 (up to 8 times, p < 0.01), especially pronounced in patients with UCEC of reproductive age. It was combined with the absence of changes or with a decreasing in blood level of su-PAR by more than 40 % (p < 0.05). We observed a rise of u-PA blood level without changes in one´s activity in patients with LM of perimenopausal age. And in patients with LM and UCEC of postmenopausal age an increase in u-PA blood level as well as elevation of u-PA activity (up to 3.9 times, p < 0.01–0.05) were noted. There was an increase in the calculated t-PA index (activity per unit mass) by 1.4–2.8 times (p < 0.05) in the most patients. The indicators of LM patients were characterized by the minimum value of the ratio “t-PA activity/u-PA activity in the blood” among all studied subgroups of patients. Age-related features of the researched parameters were observed more often in the cases of LM than in the cases of UCEC. The most pronounced differences between LM and UCEC were observed in patients of reproductive and postmenopausal age, characterized by stable hormonal levels. Conclusion. The participation of the plasminogen activation system in the pathogenesis of tumor lesions of the uterine body has been shown. The system’s “response” to the development of tumors in the uterus has both general characteristics and features that depend on the nature of the tumors and on the age-specific hormonal regulation of the body, which are most pronounced in postmenopausal women. The results obtained can be used in research aimed at clarifying the targets of targeted therapy for LM and UCEC in accordance with the age of patients.
- Open Access
- 21 June 2024
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 9 (2) , 28-36
cAMP Content in Mitochondria of Cardiomyocytes in C57bl/6 Mice With B16/F10 Melanoma in the Background of Chronic Neuropathic Pain
Aim. To study the effect of malignant tumor growth on level of cAMP in mitochondria of cardiomyocytes in mice with chronic neuropathic pain.Materials and Methods. С57ВL/6 mice (n = 336) have been grouped as follows: intact mice (♂n = 21; ♀n = 21), mice with chronic neuropathic pain (♂n = 21; ♀n = 21), mice with melanoma В16/F10 (♂n=63; ♀n=63), and mice with melanoma В16/ F10 and chronic neuropathic pain (♂n=63; ♀n=63). After 1, 2, and 3 weeks of the melanoma growth, cardiac mitochondria of abovementioned mice have been isolated by the centrifugation with the following measurement of cAMP.Results. Chronic neuropathic pain has induced a 3.6-fold reduction in cAMP in cardiac mitochondria of female mice. In mice with melanoma В16/ F10, cardiac cAMP showed 4-fold average increase from the 2nd week of the tumor growth, while in mice with melanoma В16/F10 and chronic neuropathic pain a 2-4-fold increase in cAMP was recorded as soon as from the 1st week of tumor growth, eventually leading to the depletion of cAMP by the 3rd week of the experiment. Serum cAMP concentration did not correlate with the cAMP level in cardiac mitochondria and was reduced in both males and females.Conclusion. Alterations in cAMP concentration in cardiac mitochondria were gender-specific, as female mice responded to a chronic neuropathic pain without other triggers. In mice with melanoma and chronic neuropathic pain, cAMP level raised significantly earlier than in mice without chronic neuropathic pain, resulting in full cAMP depletion by the 3rd week of the experiment.
- 21 June 2024
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 9 (2) , 28-36
Open AccesscAMP Content in Mitochondria of Cardiomyocytes in C57bl/6 Mice With B16/F10 Melanoma in the Background of Chronic Neuropathic Pain
Aim. To study the effect of malignant tumor growth on level of cAMP in mitochondria of cardiomyocytes in mice with chronic neuropathic pain.Materials and Methods. С57ВL/6 mice (n = 336) have been grouped as follows: intact mice (♂n = 21; ♀n = 21), mice with chronic neuropathic pain (♂n = 21; ♀n = 21), mice with melanoma В16/F10 (♂n=63; ♀n=63), and mice with melanoma В16/ F10 and chronic neuropathic pain (♂n=63; ♀n=63). After 1, 2, and 3 weeks of the melanoma growth, cardiac mitochondria of abovementioned mice have been isolated by the centrifugation with the following measurement of cAMP.Results. Chronic neuropathic pain has induced a 3.6-fold reduction in cAMP in cardiac mitochondria of female mice. In mice with melanoma В16/ F10, cardiac cAMP showed 4-fold average increase from the 2nd week of the tumor growth, while in mice with melanoma В16/F10 and chronic neuropathic pain a 2-4-fold increase in cAMP was recorded as soon as from the 1st week of tumor growth, eventually leading to the depletion of cAMP by the 3rd week of the experiment. Serum cAMP concentration did not correlate with the cAMP level in cardiac mitochondria and was reduced in both males and females.Conclusion. Alterations in cAMP concentration in cardiac mitochondria were gender-specific, as female mice responded to a chronic neuropathic pain without other triggers. In mice with melanoma and chronic neuropathic pain, cAMP level raised significantly earlier than in mice without chronic neuropathic pain, resulting in full cAMP depletion by the 3rd week of the experiment.